Učitavanje...
Palbociclib in metastatic breast cancer: current evidence and real-life data
The purpose of this review is to summarize the background and latest evidence for the use of palbociclib, an oral, first-in-class, highly selective cyclin-dependent kinase 4/6 inhibitor, in advanced breast cancer, with a focus on some of the unanswered questions about the performance of this agent i...
Spremljeno u:
| Izdano u: | Drugs Context |
|---|---|
| Glavni autori: | , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
BioExcel Publishing Ltd
2019
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6668507/ https://ncbi.nlm.nih.gov/pubmed/31391852 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7573/dic.212579 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|